Livestream Schedule
July 8th: The History of Hemophilia B Treatment
July 15: Extended Half-Life Therapies
July 22: Understanding Inhibitor Treatment
July 29: Rebalancing Agents
August 5: A Closer Look at HYMPAVZI®
August 12: Gene Therapy
August 19: Future Treatment Innovations
August 26: Treatment Considerations for Women
About the Program
The pace of innovation in hemophilia B has never been greater. From extended half-life therapies and rebalancing agents to gene therapy and emerging treatments still on the horizon, individuals and families are navigating more options than ever before.
Join Dr. David Clark for an eight-week educational series designed to help participants better understand the evolution of hemophilia B treatment and the innovations shaping the future of care. Together, we'll explore how treatment has progressed over time, examine current therapeutic approaches, discuss the benefits and considerations of different options, and take a closer look at the research and advancements that may influence care in the years ahead.
Whether you are newly diagnosed, evaluating treatment options, supporting a loved one, or simply curious about where the field is headed, Innovation Lab offers an opportunity to learn, ask questions, and build confidence in understanding the rapidly changing treatment landscape.
🗓 Program Details
8-Week Virtual Series
Wednesdays at 8 PM ET
July 8 – August 26
30-minute guided sessions